Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
BMC Research Notes|December 4, 2009
Comparison of threshold selection methods for microarray gene co-expression matricesBhavesh R Borate, Elissa J Chesler, Michael A Langston, et al.Vaccine|April 30, 2017
Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin AmericaEduardo Lopez-Medina, Mario Melgar, James T Gaensbauer, et al.The Lancet. Infectious Diseases|August 31, 2015
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority studyMiguel O'Ryan, Ananda S Bandyopadhyay, Rodolfo Villena, et al.Lancet (London, England)|May 24, 2016
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trialEdwin J Asturias, Ananda S Bandyopadhyay, Steve Self, et al.AIDS and Behavior|March 17, 2023
Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South AfricaMookho Malahleha, Fatima Laher, Athmanundh Dilraj, et al.Plos Computational Biology|April 2, 2019
Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence featuresCraig A Magaret, David C Benkeser, Brian D Williamson, et al.Nature Medicine|August 8, 2018
Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral reboundAfam A Okoye, Scott G Hansen, Mukta Vaidya, et al.Science Translational Medicine|May 24, 2023
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responsesKristen W Cohen, Stephen C De Rosa, William J Fulp, et al.Pageof 1